CIK 0001360214 · Large accelerated filer
HARROW, INC.
Sign in to watch- Ticker
- HROW
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 450567010
- Phone
- 615.733.4731
- Business address
- 1A BURTON HILLS BLVD, SUITE 200, NASHVILLE, TN
- Former names
- HARROW HEALTH, INC., Imprimis Pharmaceuticals, Inc., TRANSDEL PHARMACEUTICALS INC, Bywater Resources, Inc
- 8-K Event Acquisition or sale completed
- 8-K Event Material agreement
- 8-K Event Agreement ended
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Results of operations
- 4 Option exercise Chief Executive Officer acquired 200,000 shares (option exercise)
- 4 Shares withheld for taxes Chief Financial Officer gave up 7,500 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- SEC STAFF LETTER Other SEC Staff Letter Redacted Exhibit
- SC 13G/A Stake Amended Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
- SC 13G Stake Amended Statement of Ownership
- 8-K Event Other events
- 8-K Event Other events
Page 16 of 44 · 872 filings